Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial

Trial Profile

Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke (CLEAR Stroke) Trial

Completed
Phase of Trial: Phase I/II

Latest Information Update: 19 Feb 2016

At a glance

  • Drugs Alteplase; Eptifibatide
  • Indications Embolism and thrombosis; Stroke
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms CLEAR
  • Most Recent Events

    • 19 Feb 2016 Results of pooled analysis (n=247) of this and other 2 trials (CLEAR-ER and CLEAR-FDR) presented at the 41st International Stroke Conference
    • 01 Dec 2008 Primary endpoint results published in Stroke 39: 3268-3276, No. 12, Dec 2008
    • 06 Dec 2007 Status changed from in progress to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top